- Home
- GCMG vs BVS Comparison
GCMG vs BVS Comparison
Compare GCMG & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GCMG | BVS |
|---|---|---|
| Founded | 1971 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 805.6M | 929.6M |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GCMG | BVS |
|---|---|---|
| Price | $13.02 | $13.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $15.50 | ★ $17.60 |
| AVG Volume (30 Days) | 371.9K | ★ 408.8K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | ★ 3.72% | N/A |
| EPS Growth | ★ 1300.00 | 163.46 |
| EPS | 0.17 | ★ 0.52 |
| Revenue | $557,565,000.00 | ★ $568,087,000.00 |
| Revenue This Year | $5.87 | $6.46 |
| Revenue Next Year | $14.24 | $6.74 |
| P/E Ratio | $76.35 | ★ $26.91 |
| Revenue Growth | ★ 8.47 | N/A |
| 52 Week Low | $9.30 | $6.37 |
| 52 Week High | $14.87 | $15.89 |
Technical Indicators
Market Signals| Indicator | GCMG | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 46.60 | 52.37 |
| Support Level | $12.40 | $13.44 |
| Resistance Level | $13.46 | $14.71 |
| Average True Range (ATR) | 0.38 | 0.44 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 48.15 | 75.14 |
Price Performance
Historical ComparisonAbout GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG, and absolute return strategies. The company invests maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.